Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001019695-11-000026)

Filing Details

Accession Number:: 0001019695-11-000026
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-05-26 11:05:28
Reporting Period:: 2011-05-25

Filing Date:: 2011-05-26
Accepted Time:: 2011-05-26 10:05:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1019695	Arqule Inc	ARQL	Pharmaceutical Preparations (2834)	043221586

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1233414	D Michael Loberg	C/O Arqule, Inc. 19 Presidential Way Woburn MA 01801		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-05-25	1,398	$6.32	40,724	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Reflects the weighted average price as the shares were purchased in multiple transactions. The per share transaction price ranged from $6.30 to $6.35. The Reporting Person hereby undertakes to provide, upon request, by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.